Summary of Significant Accounting Policies - In-Licensing Arrangements - Development (Details) - Option and license agreement - Zymeworks Inc $ in Millions |
1 Months Ended |
---|---|
Apr. 30, 2022
USD ($)
| |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Commercial option to extend research license | 2 years |
Upfront consideration for purchase of license | $ 5.0 |
Term of the research license | 2 years |
Research and development | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Upfront consideration for purchase of license | $ 5.0 |